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Abstract
BACKGROUND—Adolescents and young adults (AYA) ages 15 to 29 years who are diagnosed 
with cancer are at risk for long-term morbidity and mortality associated with treatment of their 
cancer and the cancer itself. In this article, the authors describe the self-reported health status of 
AYA cancer survivors.
METHODS—The authors examined 2009 data from the Behavioral Risk Factor Surveillance 
System, including demographic characteristics, risk behaviors, chronic conditions, health status, 
and health care access, among AYA cancer survivors compared with respondents who had no 
history of cancer.
RESULTS—The authors identified 4054 AYA cancer survivors and 345,592 respondents who had 
no history of cancer. AYA cancer survivors, compared with respondents who had no history of 
cancer, reported a significantly higher prevalence of current smoking (26% vs 18%); obesity (31% 
vs 27%); chronic conditions, including cardiovascular disease (14% vs 7%), hypertension (35% vs 
29%), asthma (15% vs 8%), disability (36% vs 18%), and poor mental health (20% vs 10%) and 
physical health (24% vs 10%); and not receiving medical care because of cost (24% vs 15%).
CONCLUSIONS—AYA cancer survivors commonly reported adverse behavioral, medical, and 
health care access characteristics that may lead to poor long-term medical and psychosocial 
outcomes. Increased adherence to established follow-up guidelines may lead to improved health 
among AYA cancer survivors.*
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There have been improvements in cancer survival in the overall population of the United 
States over the last 30 years. However, adolescents and young adults (AYAs) have not 
experienced the same improvements as others with cancer.1–3 AYA cancer survivors—those 
ages 15 to 29 years at their first cancer diagnosis—have not experienced improvements in 
survival to the extent that younger children and older adults have.4 AYA cancer survivors 
also are at risk for long-term morbidity and mortality associated with treatment of their 
cancer and the cancer itself. Long-term survivors of cancers that were diagnosed during 
adolescence have an increased risk of death beyond 5 years compared with other cancer 
survivor populations.3,5,6 Among young adults, excess mortality is caused by cancer 
recurrence, subsequent neoplasms, and cardiovascular and lung disease as a result of 
treatment of the original cancer.3,7 Lifelong follow-up care is recommended for AYA cancer 
survivors, because this population is at risk for developing late effects related to their cancer 
treatments years later.3,5–10 However, providing follow-up care and tracking the long-term 
outcomes of AYA cancer survivors have been challenging. Most AYA cancer survivors are 
not followed in cancer survivorship programs and often are cared for by primary care 
physicians who may be unaware of the risks associated with AYA cancer and therapy.3,11
Although the health status of other populations of cancer survivors has been well 
characterized, less is known about AYA cancer survivors.3,12,13 For the current study, we 
used the 2009 Behavioral Risk Factor Surveillance System (BRFSS) to describe 
demographic characteristics, risk behaviors, chronic conditions, health status, and health 
care access among AYA cancer survivors in the United States.
MATERIALS AND METHODS
The BRFSS is a state-based surveillance system that monitors health behaviors, chronic 
diseases, injuries, access to health care, and preventive health care on an ongoing basis. 
BRFSS methodology has been published elsewhere.14,15 The 2009 BRFSS survey included 
all 50 states, the District of Columbia, Puerto Rico, the US Virgin Islands, and Guam. The 
BRFSS is a cross-sectional, random-digit-dial telephone survey of noninstitutionalized 
adults aged ≥18 years that uses trained interviewers and standard core and optional 
questionnaire modules to collect uniform data across all states, Washington DC, and select 
US territories. Surveys are conducted with US households each month using 
disproportionate, stratified, random sampling in all states and Washington DC and simple 
random sampling in Guam, Puerto Rico, and the US Virgin Islands (available from: http://
www.cdc.gov/brfss/technical_infodata/surveydata/2009.htm [Accessed January 23, 2012]). 
The median response rate according to the Council of American Survey Research 
Organization for the 2009 BRFSS was 52.5%.16
For 2009, the BRFSS included the cancer survivor module as a core module that was asked 
by all states, Washington DC, and territories. Respondents were asked whether they were 
ever told by a physician, nurse, or other health care professional that they had cancer. If 
respondents indicated ‘‘yes,’’ then they were asked how many different types of cancer they 
had, the age when they were told that they had cancer, and what type of cancer they had. Of 
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432,607 BRFSS respondents, 411,654 answered the ‘‘ever had cancer’’ question. Among 
these respondents, 45,541 reported ever having cancer (excluding nonmelanoma skin cancer; 
n = 13,632), and 348,229 reported never having any type of cancer. Respondents with an 
unknown history of cancer or who refused to answer the question were excluded from the 
analysis (n = 4252).
We conducted a descriptive analysis to obtain prevalence estimates with 95% confidence 
intervals for demographic characteristics, risk behaviors, chronic medical conditions, and 
preventive medical care among AYA cancer survivors and respondents who reported not 
having a history of cancer. We defined AYA cancer survivors as cancer survivors whose age 
at first cancer diagnosis was between ages 15 and 29 years. However, we only had data from 
survivors who were aged 18 years at the time of the interview, because the BRFSS only 
interviews individuals aged ≥18 years. Therefore, all patients who were diagnosed at age 15 
years were at least 3 years out from their cancer diagnosis. We excluded AYA cancer 
survivors who did not report their current age (n = 15), which left 4054 AYA survivors in the 
final analysis. Respondents without a history of cancer and with a known age (n = 345,592) 
served as a comparison group.
For AYA cancer survivors, we calculated the number of years since diagnosis using the 
respondents’ current age and their age at first cancer diagnosis. We grouped years since 
diagnosis as 0 to 9 years, 10 to 19 years, and ≥20 years. Type of cancer was grouped as non-
Hodgkin lymphoma, Hodgkin lymphoma, leukemia, melanoma, cervical cancer, other 
female reproductive cancer (ovarian, endometrial), male reproductive cancer (prostate, 
testicular), thyroid, brain, female breast, colorectal cancer, other, and unknown/refused.
We examined the following demographic characteristics: age at interview, sex, racial/ethnic 
background, marital status, education level, employment status, and US Census region of 
residence. In addition, we analyzed current smoking status, binge drinking (males who had 
≥5 and females who had ≥4 alcoholic drinks on 1 occasion in the past month), obesity (body 
mass index ≥30 kg/m2), no leisure-time physical activity in the past month, and <5 servings 
of fruits and vegetables per day. We analyzed the following chronic health conditions: 
cardiovascular disease (history of myocardial infarction, angina, coronary disease, or 
stroke), hypertension, diabetes, current asthma, and disability (activity limitations because of 
physical, mental, and emotional problems). Physically and mentally unhealthy days were 
categorized as 0 to13 days and ≥14 days during the past 30 days. The following health care 
access variables also were examined: health insurance coverage, inability to visit a physician 
because of cost in the past 12 months, access to a personal health care provider, and a 
routine checkup in the past 2 years.
Final survey weights were included that represented each respondent’s probability of being 
selected for the survey in their respective state or territory and were adjusted to race/
ethnicity-specific, age-specific, and sex-specific population numbers from current census 
data (or intercensal estimates). All estimates were weighted to represent noninstitutionalized 
adults aged ≥18 years living within their respective state, Washington DC, Puerto Rico, US 
Virgin Islands, or Guam. We used the SAS statistical software package (version 9.2; SAS 
Institute Inc., Cary, NC) and SAS-callable SUDAAN (release 10; Research Triangle 
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Institute, Research Triangle Park, NC) to account for the complex sampling design of the 
BRFSS. Because AYA cancer survivors tended to be largely female and younger compared 
with respondents who had no history of cancer, all prevalence estimates with the exception 
of those for years since diagnosis, age at interview, type of cancer, and sex were age-
standardized and sex-standardized to the total BRFSS population. We used use 
nonoverlapping 95% confidence intervals as a measure of significance.
RESULTS
We identified 4054 AYA cancer survivors and 345,592 respondents who had no history of 
cancer (Table 1). AYA cancer survivors had a significantly younger median age at interview 
(40 years) compared with respondents who had no history of cancer (43 years). The most 
common identified type of cancer among AYA cancer survivors was cervical cancer (38%), 
followed by other female reproductive cancer (13%), and melanoma (9%). Significantly 
lower proportions of AYA cancer survivors were non-Hispanic blacks and Hispanics (6% 
and 8%, respectively) compared with respondents who had no history of cancer (10% and 
15%, respectively). A significantly greater proportion of AYA cancer survivors reported 
being out of work/unable to work (24%) compared with respondents who had no history of 
cancer (14%).
Table 2 lists risk behaviors, chronic medical conditions, self-reported healthy days, and 
health care access. Current smoking was significantly greater among AYA cancer survivors 
(26%) compared with respondents who had no history of cancer (18%). There was no 
difference in binge drinking between AYA cancer survivors and respondents who had no 
history of cancer (14% vs 15%). More AYA cancer survivors also reported no leisure-time 
physical activity in the past month compared with respondents who had no history of cancer 
(31% vs 24%). Compared with respondents who had no history of cancer, AYA cancer 
survivors had a greater prevalence of cardiovascular disease (14% vs 7%), hypertension 
(35% vs 29%), disability (36% vs 18%), asthma (15% vs 8%), and diabetes (12% vs 9%). 
Compared with respondents who had no history of cancer, a greater proportion of AYA 
cancer survivors reported ≥14 days of poor mental health in the past 30 days (20% vs 10%) 
or poor physical health (24% vs 10%) in the past 30 days. There was no statistical difference 
in health insurance, personal health care providers, or a physician checkup in the past 2 
years between the 2 groups. However, a significantly greater proportion of AYA cancer 
survivors reported not being able to visit a physician because of cost (24% vs 15%). Because 
of the large number of self-reported cervical cancer survivors, we also performed our 
analysis excluding cervical cancer survivors. After removing cervical cancer survivors from 
the overall group of cancer survivors, only 2 estimates were statistically significantly 
changed: sex and individuals reporting “other” for employment status.
DISCUSSION
In this report, we describe the health status of AYA cancer survivors in the United States 
using BRFSS data. Our findings reveal that AYA cancer survivors commonly reported 
unhealthy behaviors, chronic medical conditions, poor health-related quality of life, and 
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significant barriers to health care access, which may lead to poor long-term medical and 
psychosocial outcomes.
Our results are consistent with previous literature describing adverse health conditions, 
including smoking, chronic medical problems, functional limitations, and poor self-reported 
health status, among various cancer survivor populations.17–22 Evidence suggests that 
modifiable risk behaviors among cancer survivors, including smoking, alcohol use, and 
obesity, may be associated with cancer recurrences and the development of second primary 
cancers.23 Cancer survivors, including adolescent cancer survivors, who continue to smoke 
are at increased risk for second malignancies and chronic conditions.24,25 Despite this risk, 
26% of AYA cancer survivors reported current smoking. This was significantly higher than 
the proportion of respondents who had no history of cancer and it also was higher than 
previous reports of current smoking among childhood, adolescent, and adult cancer 
survivors.26–30 This highlights an important public health problem that may benefit from 
effective cessation interventions, such as peer-delivered smoking counseling.31 Although 
effective tobacco treatment programs exist, research suggests that health care providers miss 
opportunities to provide smoking-cessation advice and treatment.32 Our results suggest that 
AYA cancer survivors should be a priority for interventions to prevent the initiation of 
smoking and for smoking-cessation interventions.33 This is especially true for adolescents, 
because their intention to smoke is closely correlated to future smoking.33 Limiting alcohol 
use also has been suggested for cancer survivors given the potential mutagenic effects of 
alcohol that may place cancer survivors at risk for second cancers or increased late 
effects.30,34,35 Despite these risks, there was a similar proportion of binge drinking among 
AYA cancer survivors compared with respondents who had no history of cancer. This 
indicates a need for interventions to decrease the initiation and consumption of alcohol 
among AYA cancer survivors. We also observed that a significantly greater proportion of 
AYA cancer survivors were obese and reported no leisure-time physical activity in the past 
month compared with respondents who had no history of cancer. Although research suggests 
that vigorous physical activity increases survival among survivors of breast and colorectal 
cancer,36–38 exercise training is likely to be beneficial for most cancer survivors.39,40 The 
American College of Sports Medicine has indicated that exercise training sufficiently 
improves physical functioning and quality of life for cancer survivors.40 The lack of physical 
activity among cancer survivors may be because of physical limitations as a result of cancer 
treatment and the cancer itself. Therefore, the availability of individualized physical fitness 
programs, such as Live-Strong at the YMCA, may be of benefit to cancer survivors.41
A significantly greater proportion of AYA cancer survivors reported having cardiovascular 
disease, hypertension, asthma, and diabetes compared with respondents who had no history 
of cancer. This is consistent with late effects of cancer treatment, including cardiac and 
pulmonary complications, among childhood cancer survivors.34,42 The increased incidence 
of medical conditions, such as diabetes, may be from the increased rate of obesity in cancer 
survivors compared with the general population and may not be caused solely by late effects 
of cancer therapy.36,43,44 Long-term follow-up guidelines published by the Institute of 
Medicine and the Children’s Oncology Group (COG) recommend lifelong follow-up care 
for childhood, adolescent, and young adult cancer survivors based on cancer history and 
treatment.45,46 COG recommendations provide guidance on potential late effects, risk 
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factors, screening and evaluation, counseling, and other interventions.46 Compared with 
young adults, children with cancer are more likely to be treated in COG-associated 
institutions. Health care providers at these COG institutions may be more likely to be aware 
of and adhere to the COG long-term follow-up guidelines compared with other hospitals. 
Therefore, young adults may receive care from health care providers who are not as familiar 
with guidelines recommending appropriate follow-up for AYA cancer survivors. Efforts to 
improve providers’ knowledge and use of recommended guidelines, such as the American 
Society of Clinical Oncology and LiveStrong’s Focus Under Forty program,47 are needed to 
address the numerous health needs of AYA cancer survivors. Improving the quality of care 
for AYA cancer survivors also may include the use of survivorship care plans, which were 
recommended by the Institute of Medicine in 2006.48,49 Survivorship care plans are 
designed to improve the quality of care for cancer survivors through summarizing cancer 
treatments, describing potential late effects of treatment and cancer, recommending 
appropriate screening, and promoting healthy behaviors.49,50
We observed that a greater proportion of AYA cancer survivors reported disability compared 
with respondents who had no history of cancer. This may be because of the late effects of 
cancer treatment as opposed to aging, because AYA cancer survivors as a group were 
younger than respondents who had no history of cancer at the time of interview, and our 
results were age-adjusted. A greater proportion of AYA cancer survivors also reported more 
poor mental and physical health in the past 30 days compared with respondents who had no 
history of cancer. Our results, although they were based on different methodology and 
populations, are consistent with previous literature indicating that adolescents who are 
diagnosed with cancer report low health-related quality of life.51 Disability also has been 
associated with poor health-related quality of life and risk behaviors, including smoking, 
lack of physical activity, and obesity.18 Our results indicate that this combination of 
disability and risk factors may be particularly problematic for AYA cancer survivors.
Although we observed no differences between the AYA population and respondents and 
noncancer controls in terms of health insurance status, a significantly greater proportion of 
AYA cancer survivors could not visit a physician because of cost. This may be because of 
financial strain caused by the high cost of cancer treatment, which results in an inability to 
pay for copayments, medications, transportation, and other services.52,53 This is consistent 
with studies indicating that, compared with individuals who have no history of cancer, 
cancer survivors are more likely both to delay and to forgo medical services because of 
cost.53 The inability to visit a physician because of cost also potentially may be related to a 
lower overall level of income in cancer survivors. Lower income in this population 
potentially may be a long-term result of derailment of patients’ education/employment 
trajectories during their cancer treatment and may be unrelated to any lingering effects of the 
cost of cancer therapy.
Our study has several limitations. BRFSS data are self-reported and may be subject to recall 
or social desirability bias. For cancer in particular, survivors are likely to over-report and 
under-report, depending on the cancer type.54,55 Cervical cancer survivors were the largest 
self-reported group in our study, which differs from estimates reported from cancer registry 
data.56 This discrepancy may be caused by over-reporting. There is evidence that 
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respondents of health interview surveys over-report certain types of cancer, including 
cervical cancer.55 Women who are diagnosed with cervical intraepithelial neoplasia or other 
squamous cell abnormalities may mistakenly believe that they have cervical cancer. 
However, women typically are diagnosed with cervical cancer, which is highly treatable if 
detected early, at younger ages relative to other cancers, and this may contribute to a large 
cervical cancer survivor population.57 There was no medical record review to confirm self-
reported cancer type and other responses. BRFSS is administered through landline 
telephones. Therefore, there may be bias present because of the exclusion of individuals who 
do not have a landline telephone.58 BRFSS also is limited to noninstitutionalized individuals 
and may not be representative of the general population. BRFSS is not administered to 
individuals aged <18 years of age. Therefore, AYA cancer survivors younger than age 18 
years were not included in this study.
AYA cancer survivors are at risk for late effects from treatment, cancer recurrences, and 
second malignancies as a result of their cancer and its treatment. Although guidelines for 
long-term follow-up aim to prevent and minimize poor outcomes, increasing adherence to 
these guidelines and implementing evidence-based interventions to promote healthy 
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Table 1
Demographic Characteristics of Survivors of Adolescent and Young Adult Cancers and Respondents Without 
a History of Cancer: Behavioral Risk Factor Surveillance System, 2009
Percentage (95% CI)a
Characteristic Survivors of Adolescent and
Young Adult Cancer Diagnosed
at Ages 15 to 29 Yearsb
Respondents Without
a History of Cancerb
Total no.: Unweighted 4054 345,592
Total no.: Weighted 1,934,779 194,913,730
Time since diagnosis, y
  0–9 28.5 (25.5–31.8) —
  10–19 26.7 (24–29.6) —
  ≥20 44.8 (41.9–47.7) —
  Median age at interview, y 40.2 (38.7–41.4) 42.9 (42.8–43.1)
Type of cancer
  Non-Hodgkin lymphoma 2.4 (1.2–4.7) —
  Hodgkin lymphoma 5.3 (4–7) —
  Leukemia 1.5 (0.9–2.4) —
  Melanoma 8.5 (7.2–10) —
  Cervical 37.7 (34.8–40.6) —
  Other female reproductive 13.1 (11.1–15.4) —
  Male reproductive 2.9 (2.1–4.1) —
  Thyroid 3.7 (2.9–4.9) —
  Brain 1 (0.6–1.8) —
  Female breast 4.8 (3.9–5.9) —
  Colorectal 1.5 (1–2.3) —
  Other 14.5 (12.5–16.9) —
  Unknown/refused 3 (2.1–4.3)
Sex
  Male 18.9 (16.4–21.7) 49.2 (48.8–49.6)
  Female 81.1 (78.3–83.6) 50.8 (50.4–51.2)
Race/ethnicity
  White, non-Hispanic 78.5 (75–81.6) 67.5 (67.2–67.9)
  Black, non-Hispanic 6.1 (4.7–7.9) 10.3 (10.1–10.5)
  Native Hawaiian/Asian/Pacific
    Islander, non-Hispanic
—c 3.6 (3.4–3.8)
  AI/AN, non-Hispanic 1.4 (1–1.9) 1 (1–1.1)
  Hispanic 7.9 (5.8–10.6) 14.7 (14.4–15)
  Multiracial 3.8 (2.2–6.4) 1.5 (1.4– 1.6)
Education
  <High school 10.3 (8.6–12.3) 10.6 (10.4–10.9)
  High school graduate 27.5 (24–31.2) 28.1 (27.8–28.4)
  Some college 29.3 (25.6–33.3) 26.6 (26.3–26.9)
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Percentage (95% CI)a
Characteristic Survivors of Adolescent and
Young Adult Cancer Diagnosed
at Ages 15 to 29 Yearsb
Respondents Without
a History of Cancerb
  College graduate 32.9 (29.7–36.3) 34.6 (34.3– 34.9)
Employment
  Employed for wages 49.4 (45.4–53.5) 57.5 (57.2–57.8)
  Out of work/unable to work 23.5 (19.9–27.5) 13.7 (13.5–14)
  Other 10.6 (8.5–13.3) 12.8 (12.6–13.1)
  Retired 16.2 (14.3–18.3) 15.7 (15.5–15.8)
US Census region of residence
  Northeast 16.1 (13.6–19) 18.1 (17.9–18.3)
  Midwest 22.6 (19.2–26.4) 22.1 (21.9–22.3)
  South 39.1 (35.4–43) 36.5 (36.2–36.8)
  West 21.9 (19.1–24.9) 21.9 (21.7–22.1)
Abbreviations: AI/AN, American Indian/Alaska Native; CI, confidence interval.
a
Cancer survivors with nonmelanoma skin cancer were excluded. All estimates other than age, sex, years since diagnosis, number of cancers, and 
cancer type are age and sex standardized.
b
Ninety-five percent CI percentages may not total 100% because of rounding. Unknown/refused categories are suppressed for most variables; 
therefore, percentages may not add to 100%. Data for territories are suppressed.
c
Data suppressed, number of respondents < 30.
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Table 2
Risk Behaviors, Chronic Conditions, Self-Reported Health Status, and Health Care Access Among Survivors 
of Adolescent and Young Adult Cancers and Respondents Without a History of Cancer: Behavioral Risk 
Factor Surveillance System, 2009
Percentage (95% CI)
Characteristic Survivors of Adolescent and
Young Adult Cancer Diagnosed
at Ages 15 to 29 Yearsa
Respondents Without
a History of Cancera
Risk behaviors
  Current smoker 25.9 (23–28.9) 17.9 (17.6–18.1)
  Binge drinker 13.8 (11.1–17) 15.1 (14.8–15.3)
  Obese: BMI ≥30 kg/m2 30.8 (27.2–34.7) 26.7 (26.4–27)
  No leisure-time physical activity in past mo 30.5 (27.2–33.9) 24.3 (24–24.6)
  <5 Servings of fruits/vegetables 78.7 (76.1–81.2) 76.3 (76–76.6)
Chronic conditions
  Cardiovascular disease 14.2 (11.7–17.2) 7.4 (7.3–7.5)
  Hypertension 35.1 (31.6–38.7) 29.1 (28.9–29.4)
  Disability 36.3 (32.4–40.3) 18.1 (17.9–18.3)
  Current asthma 15.2 (12.7–18.1) 8.3 (8.1–8.4)
  Diabetes 11.8 (10–14) 9 (8.9–9.2)
Poor mental health in past 30 d
  0–13 d 79.7 (76.6–82.5) 88.6 (88.4–88.9)
  ≥14 d 19.5 (16.7–22.6) 10.2 (10–10.4)
Poor physical health in past 30 d
  0–13 d 73.7 (69.4–77.5) 88.4 (88.2–88.6)
  ≥14 d 23.9 (20.3–28.1) 10.1 (9.9–10.3)
Health care access
  No health insurance access 15 (12.2–18.4) 15.2 (14.9–15.5)
  Could not see a physician because of cost 23.9 (20.5–27.6) 14.7 (14.4–15)
  Had personal health care provider 86.2 (83.4–88.6) 80.8 (80.5–81.1)
  Saw a physician for checkup in past 2 y 82.4 (79.5–84.9) 81.3 (81–81.6)
Abbreviations: CI, confidence interval; BMI, body mass index.
a
Cancer survivors with nonmelanoma skin cancer were excluded. All estimates are age and sex adjusted to the Behavioral Risk Factor Surveillance 
System, population.
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